Published : 27 Mar 2026

---

Aagami is pleased to announce a new strategic client win with a pioneering France-headquartered pharmaceutical company. Under this newly signed mandate, Aagami will leverage its global network and industry expertise to identify and secure high-value cross-border strategic partnerships for the client.

The client is an innovator in the drug delivery space, dedicated to the development, manufacturing, and commercialization of a cutting-edge needle-free drug auto-injector technology designed to improve patient compliance and delivery efficiency.

Key Scope of Engagement

• Global Matchmaking & Introductions: Identifying, qualifying, and initiating introductions with strategic targets, affiliated entities, and key stakeholders aligned with the client's growth objectives.
• Transaction & Negotiation Support: Providing end-to-end assistance throughout discussions, developing tailored negotiation materials, and delivering strategic input leading up to the execution of Definitive Agreements.
• Commercial Intelligence: Delivering targeted business intelligence and market insights to support executive decision-making and maximize partnership value.

This engagement underscores Aagami’s commitment to bridging innovative global life science companies with the right strategic partners to accelerate commercial success.